Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Observational Study of Clot-Removal Procedure for Stroke in the Middle East and North Africa

Follows people with acute stroke from large blood clots who receive mechanical thrombectomy.

Plain-language title generated from the registry record
Registry title: Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry

Key facts

Where
Alexandria, EgyptSee the site

Where in Egypt

  • Alexandria University Stroke networkAlexandria, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Middle East North Africa Stroke and Interventional Neurotherapies Organization
Trial code
NCT06702787
Record updated
25 November 2024
Original description
The MEMENTO (MEchanical thrMobectomy NETwork for MENA TOgether) Registry is a multicenter, prospective observational study aiming to evaluate the effectiveness, safety, and cost-effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusions (LVO) in the Middle East and North Africa (MENA) region. This interim analysis reports on the first 499 patients enrolled, assessing clinical outcomes, procedural details, and economic implications.Read full original descriptionShow less

Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry

The MEMENTO (MEchanical thrMobectomy NETwork for MENA TOgether) Registry is a multicenter, prospective observational study aiming to evaluate the effectiveness, safety, and cost-effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusions (LVO) in the Middle East and North Africa (MENA) region. This interim analysis reports on the first 499 patients enrolled, assessing clinical outcomes, procedural details, and economic implications.

Inclusion: Adults aged 18 years and older (no upper age limit). Diagnosed with acute ischemic stroke due to confirmed large vessel occlusion (LVO) or medium vessel occlusion (MeVO); Underwent mechanical thrombectomy (MT) with or without prior intravenous thrombolysis (IV tPA); Pre-stroke modified Rankin Scale (mRS) score of 0-5. Consent to participate in the registry (by patient or legal representative).

Exclusion: Absence of confirmed LVO or MeVO. Pre-stroke mRS score of 6. Known severe comorbid conditions precluding MT. Inability to obtain informed consent. Patients not treated with MT.

ClinicalTrials.gov NCT06702787